This week on Contemporary OB/GYN: November 16 to November 20

Article

What to look for this week on Contemporary OB/GYN

You can expect a variety of topics to be covered this week on Contemporary OB/GYN, including:

Cost-effectiveness of STI screenings in emergency departments

Are targeted screenings for sexually transmitted infections (STIs) or universally offered screenings more cost-effective than not screening?

Having children at home and risk of COVID-19 in pregnancy

Researchers from Northwestern University Feinberg School of Medicine say that women who have children at home may be at higher risk of severe COVID-19 in pregnancy.

Did you follow our coverage of the American Association of Gynecologic Laparoscopists’ (AAGL) 2020 Virtual Global Congress?

We covered a wide range of topics and presentations. See our conference coverage for more information.

S2E7: Surgeons’ Panel Discussion on the state of gynecologic surgery

This episode of Pap Talk by Contemporary OB/GYN features a panel discussion led by our deputy editor, Jon I. Einarsson, MD, MPH, PhD, that focuses on technology and weighing pros and cons of existing and newly developed platforms.

Check back soon for additional updates.

Recent Videos
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Elinzanetant displays positive phase 3 safety and efficacy data against VMS | Image Credit: © toeytoey - © toeytoey - stock.adobe.com.
© 2024 MJH Life Sciences

All rights reserved.